Mineralocorticoid receptor antagonist therapy in patients with ischemic heart failure and ventricular tachycardia: a comparative analysis of spironolactone vs. eplerenone
Left and right ventricular function measured by strain analysis predicts one-year mortality in ventricular tachycardia ablation patients with structural heart disease
Event:
EHRA 2024
Topic:
Ablation of Ventricular Arrhythmias
Session:
Poster session on ventricular tachycardia, others